Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance
2023 · Nature Communications · 61 citations
https://doi.org/10.1038/s41467-023-35995-2
X
Xiong Zou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
107
Papers
3.2K
Citations
29
h-index
56
i10-index
Xiong Zou is an academic researcher from Guiyang Medical University. The author has contributed to research in topics: Head and Neck Cancer Studies & Head and Neck Surgical Oncology & Cancer Immunotherapy and Biomarkers. The author has an h-index of 29, co-authored 91 publications.
ORCID: 0000-0002-4524-8750Papers by this author
worksEfficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial
2023 · Cell Reports Medicine · 22 citations
https://doi.org/10.1016/j.xcrm.2023.101279
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 study
2023 · EClinicalMedicine · 17 citations
https://doi.org/10.1016/j.eclinm.2023.102043
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinoma
2024 · Cell Reports Medicine · 6 citations
https://doi.org/10.1016/j.xcrm.2024.101779
Predictive value of nasopharyngeal microbiota for necrosis after re-irradiation in recurrent nasopharyngeal carcinoma
2025 · BMC Cancer · 0 citations
https://doi.org/10.1186/s12885-025-14842-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat